Table 1.
Non-associating engineered photoreceptors.
Class | Protein architecturea | Trade name | Cofactor | Size (aa)b | Activation/Deactivation λmax (nm) | Dark recoveryc | Optogenetic application |
---|---|---|---|---|---|---|---|
LOV | AsLOV2-EcTrpR | LOV-TAP | FMN | 240 | 450/dark | Seconds | DNA binding (Strickland et al., 2008) |
AsLOV2 inserted into EcDHFR | – | FMN | 300 | 450/dark | Seconds | Enzymatic activity (Lee et al., 2008) | |
AsLOV2-HsRac1 | PA-Rac1 | FMN | 320 | 450/dark | Seconds | GTPase signaling (Wu et al., 2009) | |
AsLOV2-HsStim1 | LOVS1K | FMN | 360 | 450/dark | Seconds | Ion channel activation (Pham et al., 2011) | |
AsLOV2-HsCaspase 7 | L57V | FMN | 400 | 450/dark | Seconds | Caspase/apoptosis (Mills et al., 2012) | |
DaαDTX-AsLOV2 | Lumitoxin | FMN | 300 | 450/dark | Seconds | Ion channel inhibition (Schmidt et al., 2014) | |
AtLOV2-MmOdc1 peptide | PSD | FMN | 160 | 450/dark | Seconds | Protein degradation (Renicke et al., 2013) | |
AsLOV2-peptide | B-LID | FMN | 150 | 450/dark | Seconds | Protein degradation (Bonger et al., 2014) | |
AsLOV2-HsPKI | PA-PKI | FMN | 160 | 450/dark | Seconds | Inhibition of endogenous Ser/Thr kinases (Yi et al., 2014) | |
AsLOV2-peptide | PA-MKI | ||||||
AsLOV2-peptides | LINuS | FMN | 150 | 450/dark | Seconds | Nuclear transport (Niopek et al., 2014) | |
BsYtvA-BjFixL | YF1, YHF | FMN | 390 | Dark/450 | Minutes to hours | Prokaryotic gene expression (Möglich et al., 2009a, 2010a; Ohlendorf et al., 2012) | |
PYP | ScGCN4-HhPYP | – | pCA | 160 | 450/dark | Seconds | DNA binding (Fan et al., 2011) |
rhodopsin | BtRhodopsin-Cgβ2AR | – | Retinal | 350 | 500/dark | Seconds to minutes | cNMP signaling (Kim et al., 2005) |
BtRhodopsin-Hsα1aAR BtRhodopsin-Cgβ2AR | OptoXR | Retinal | 400 350 | 500 /dark | Seconds to minutes | cNMP and PLC signaling (Airan et al., 2009) | |
MmMelanopsin CrOpsin | – | Retinal | 500 330 | 480/lightd 500 | Seconds Seconds | cNMP and PLC signaling (Karunarathne et al., 2013) | |
MmMelanopsin-MmmGluR6 | Opto-mGluR6 | Retinal | 500 | 480/lightd | Seconds | vision restoration (Van Wyk et al., 2015) | |
RrRhodopsin-Hs5-HT1A | Rh-CT5-HT1A | Retinal | 350 | 485/dark | Seconds to minutes | Ion-channel activation (Oh et al., 2010) | |
bacterio-phytochrome | SpCph1-EcEnvZ | Cph8 | PCB | 750 | 660/720 | Minutes | Prokaryotic gene expression (Levskaya et al., 2005) |
DrBPhy-HsPDE2A | LAPD | BV | 890 | 700/750 | Minutes | cNMP hydrolysis (Gasser et al., 2014) | |
RsBPhG-NsCyaB1 | IlaC | BV | 800 | 710/760 | Minutes | cAMP formation (Ryu et al., 2014) |
Species abbreviations as follows: As, Avena sativa; At, Arabidopsis thaliana; Bj, Bradyrhizobium japonicum; Bs, Bacillus subtilis; Bt, Bos taurus; Cg, Cricetulus griseus; Cr, Carybdea rastonii; Dr, Deinococcus radiodurans; Da, Dendroaspis angusticeps; Ec, Escherichia coli; Hh, Halorhodospira halophila; Hs, Homo sapiens; Mm, Mus musculus; Ns, Nostoc sp.; Rr, Rattus rattus; Rs, Rhodobacter sphaeroides; Sc, Saccharomyces cerevisiae; Sp, Synechocystis PCC6803; “peptide” refers to a short, synthetic sequence.
Sizes are approximate.
Time scales refer to intrinsic dark-recovery reaction; note that this is temperature-dependent and may be followed by slow biological processes.
Melanopsin has been reported to be photochromic but the spectrum for deactivation has not been thoroughly determined (Ernst et al., 2014).